Page 46 - Anjali Singh

Retrofitting saves 29% for buses, 24% for trucks compared to new EVs

According to the findings, retrofitting extends the lifespan of vehicles by 8-10 years and offers a faster payback compared to new electric vehicles (EVs)

Classic Legends charts revival plan; to focus more on Asean markets

The company revealed that they are now targeting the Asean markets, starting with the Philippines

Jawa Yezdi Motorcycles plans to take on Royal Enfield with new 350 cc bike

Competing in the mid-capacity segment, the Jawa 350 will face off against the Royal Enfield Classic 350 (priced between Rs 1.93 to 2.24 lakh) and Honda H'ness CB 350 (ex-showroom Rs 2.09 - 2.16 lakh)

Cervical cancer mortality rates drop, but experts stress need for vaccine

Experts anticipate indigenous vaccine to help curb cases; health ministry yet to take a decision on rollout

Tata Motors begins production at new Sanand plant acquired from Ford

The new facility is spread over 460 acres and is adjacent to Tata Motors' existing passenger vehicle facility in Sanand

Interim Budget: MedTech industry urges govt action to cut import reliance

According to the Global Trade Research Initiative (GTRI) report on August 2023, the Indian medical devices industry has the potential to expand from $12 billion to $50 billion by 2030

Supriya Lifesciences targets Brazil, eyes Rs 200 crore sales in 2-3 years

This ambition follows the company's recent approval from Anvisa (Brazilian health regulatory agency), which has facilitated its entry into the Brazilian market

EVRE aims to capture 35% of commercial vehicle charging market by 2025

EVRE has set the target to secure a total of Rs 160 crore in equity by the end of 2024 to support its expansion plans

Cipla forges strategic partnership for global cell therapy advancements

The collaborative effort is aimed at developing and commercialising novel Cell therapy products for critical unmet medical needs in the US, Japan, and the EU

Implementing revised Schedule M rules uphill task for small pharma

Analysts also feel this move will help improve quality of Indian drugs

Indira IVF on global expansion spree, eyes overseas centre in Nepal first

This expansion is driven by a combination of factors, including the growing demand for IVF treatment in underserved markets and foreign customers coming in

Audi India records 89% sales growth in 2023, the highest since 2015

As Audi India continues to expand its retail footprint, ending 2023 with a total of 64 touchpoints nationwide, the company is confident that this momentum will carry into 2024

Indian medtech industry urges govt action to reduce import dependency

According to the Global Trade Research Initiative (GTRI) report from August 2023, the Indian medical devices industry has the potential to expand from $12 billion today to $50 billion by 2030

ICRA predicts 9-11% growth in FY24 fuelled by new launches, US rebound

ICRA anticipates expansion in revenues for its sample set of 25 companies, which represent approximately 60 per cent of the overall revenues of the Indian pharmaceutical industry

Glenmark cuts diabetes drug cost by 70% with first Indian biosimilar launch

Drug, marketed under the brand name Lirafit, is priced at approximately Rs 100 for a standard daily dose of 1.2 mg

Dr Reddy's Laboratories acquires women's health brands from MenoLabs

DRL said that it has acquired the entire MenoLabs supplements portfolio, which includes seven branded products designed to provide health support and address symptoms of perimenopause and menopause

BDR Pharmaceuticals launches prostate cancer drug in oral solution form

BDR stated since BDENZA is in liquid form, they can't quantify how lower it is compared to its counterparts in the market as they are present in solid form (tablet/capsule)

Alembic Pharmaceuticals clinches eight USFDA approvals in Q3 FY24

The same day, Alembic Pharma's share price rose to 3.55 per cent, ending the day's trade at Rs 792 apiece on the BSE

Festive cheer drives up TVS, Bajaj sales: Two-wheeler boom, export boost

Bajaj Auto reported that the domestic two-wheeler segment witnessed a 26 per cent growth, with sales climbing to 158,370 units in December 2023 from 125,553 units in December 2022

JK Tyre successfully raises Rs. 500 cr through QIP for growth initiatives

The funds raised will be utilised for both strengthening the balance sheet and growing capex